A gene trap mutagenesis screen for genes underlying cellular response to the mood stabilizer lithium

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 5, 2013, Pages 657-663

  Gow, Matthew ^a   Mirembe, Dora ^a   Longwe, Zaomba ^a   Pickard, Benjamin S ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Gene trap; Lithium; Mood stabilizer; Mutagenesis; Screen; Selection

Indexed keywords

LITHIUM;

AFFECT; ARTICLE; CELL LINE; CELLS; DRUG EFFECT; GENETIC SCREENING; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MUTAGENESIS;

AFFECT; CELL LINE; CELLS; GENETIC TESTING; HUMANS; LITHIUM; MUTAGENESIS;

EID: 84878361022     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12048     Document Type: Article

References (52)

1. Echeverri CJ, Beachy PA, Baum B, et al. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods. 2006; 3: 777-9.
2. Echeverri CJ, Perrimon N. High-throughput RNAi screening in cultured cells: a user's guide. Nat Rev Genet. 2006; 7: 373-84.
3. Joyner AL. Gene targeting and gene trap screens using embryonic stem cells: new approaches to mammalian development. BioEssays. 1991; 13: 649-56.
4. Brickman JM, Tsakiridis A, To C, et al. A wider context for gene trap mutagenesis. Methods Enzymol. 2010; 477: 271-95.
5. Skarnes WC, von Melchner H, Wurst W, et al. A public gene trap resource for mouse functional genomics. Nat Genet. 2004; 36: 543-4.
6. Niwa H, Araki K, Kimura S, et al. An efficient gene-trap method using poly A trap vectors and characterization of gene-trap events. J Biochem. 1993; 113: 343-9.
7. Hedgepeth CM, Conrad LJ, Zhang J, et al. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol. 1997; 185: 82-91.
8. Williams R, Ryves WJ, Dalton EC, et al. A molecular cell biology of lithium. Biochem Soc Trans. 2004; 32: 799-802.
9. Marmol F. Lithium: bipolar disorder and neurodegenerative diseases possible cellular mechanisms of the therapeutic effects of lithium. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 1761-71.
10. Wada A. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci. 2009; 110: 14-28.
11. Inhorn RC, Majerus PW. Inositol polyphosphate 1-phosphatase from calf brain. Purification and inhibition by Li+, Ca2+, and Mn2+. J Biol Chem. 1987; 262: 15946-52.
12. Barr RD, Harnish D. Induction of differentiation of HL-60 and WEHI-3B D+ leukemia cells by lithium chloride. Leuk Res. 1993; 17: 1017-8.
13. Garcia-Perez J, Avila J, Diaz-Nido J. Lithium induces morphological differentiation of mouse neuroblastoma cells. J Neurosci Res. 1999; 57: 261-70.
14. Schmidt MM, Guan K, Wobus AM. Lithium influences differentiation and tissue-specific gene expression of mouse embryonic stem (ES) cells in vitro. Int J Dev Biol. 2001; 45: 421-9.
15. Kim JS, Chang MY, Yu IT, et al. Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J Neurochem. 2004; 89: 324-36.
16. Misiuta IE, Saporta S, Sanberg PR, et al. Influence of retinoic acid and lithium on proliferation and dopaminergic potential of human NT2 cells. J Neurosci Res. 2006; 83: 668-79.
17. Su H, Chu TH, Wu W. Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord. Exp Neurol. 2007; 206: 296-307.
18. Toledo EM, Colombres M, Inestrosa NC. Wnt signaling in neuroprotection and stem cell differentiation. Prog Neurobiol. 2008; 86: 281-96.
19. Wexler EM, Geschwind DH, Palmer TD. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry. 2008; 13: 285-92.
20. Fatemi SH, Reutiman TJ, Folsom TD. The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder. Biochem Soc Trans. 2009; 37: 1090-5.
21. Plant KE, Anderson E, Simecek N, et al. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009; 235: 124-34.
22. Chetcuti A, Adams LJ, Mitchell PB, et al. Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment. Psychiatr Genet. 2008; 18: 64-72.
23. Seelan RS, Khalyfa A, Lakshmanan J, et al. Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells. Neuroscience. 2008; 151: 1184-97.
24. McQuillin A, Rizig M, Gurling HM. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics. 2007; 17: 605-17.
25. Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach. Part II: clinical pharmacology and therapeutic monitoring. CNS Drugs. 2009; 23: 331-49.
26. Kim SO, Ha SD. Phenotype based functional gene screening using retrovirus-mediated gene trapping in quasi-haploid RAW 264.7 cells. Methods Mol Biol. 2010; 634: 331-42.
27. Malik S, Roeder RG. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet. 2010; 11: 761-72.
28. Yoda A, Kouike H, Okano H, et al. Components of the transcriptional Mediator complex are required for asymmetric cell division in C. elegans. Development. 2005; 132: 1885-93.
29. Kim S, Xu X, Hecht A, et al. Mediator is a transducer of Wnt/beta-catenin signaling. J Biol Chem. 2006; 281: 14066-75.
30. Lin X, Rinaldo L, Fazly AF, et al. Depletion of Med10 enhances Wnt and suppresses Nodal signaling during zebrafish embryogenesis. Dev Biol. 2007; 303: 536-48.
31. Wuebben EL, Mallanna SK, Cox JL, et al. Musashi2 is required for the self-renewal and pluripotency of embryonic stem cells. PLoS ONE. 2012; 7: e34827.
32. Sakakibara S, Nakamura Y, Yoshida T, et al. RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. Proc Natl Acad Sci USA. 2002; 99: 15194-9.
33. Hoverter NP, Ting JH, Sundaresh S, et al. A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs. Mol Cell Biol. 2012; 32: 3648-62.
34. Kharas MG, Lengner CJ, Al-Shahrour F, et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med. 2010; 16: 903-8.
35. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009; 458: 223-7.
36. Marques AC, Ponting CP. Catalogues of mammalian long noncoding RNAs: modest conservation and incompleteness. Genome Biol. 2009; 10: R124.
37. Umlauf D, Fraser P, Nagano T. The role of long non-coding RNAs in chromatin structure and gene regulation: variations on a theme. Biol Chem. 2008; 389: 323-31.
38. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012; 482: 339-46.
39. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009; 136: 629-41.
40. Chodroff RA, Goodstadt L, Sirey TM, et al. Long noncoding RNA genes: conservation of sequence and brain expression among diverse amniotes. Genome Biol. 2010; 11: R72.
41. Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res. 2010; 1338: 20-35.
42. Salta E, De Strooper B. Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol. 2012; 11: 189-200.
43. Ivanova N, Dobrin R, Lu R, et al. Dissecting self-renewal in stem cells with RNA interference. Nature. 2006; 442: 533-8.
44. Thomson PA, Christoforou A, Morris SW, et al. Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry. 2007; 12: 94-104.
45. Georgieva L, Dimitrova A, Ivanov D, et al. Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol Psychiatry. 2008; 64: 419-27.
46. Goes FS, Willour VL, Zandi PP, et al. Family-based association study of Neuregulin 1 with psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2009; 150B: 693-702.
47. Prata DP, Breen G, Osborne S, et al. An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis. Psychiatr Genet. 2009; 19: 113-6.
48. Vargas JD, Herpers B, McKie AT, et al. Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases. Biochim Biophys Acta. 2003; 1651: 116-23.
49. Rogowski K, van Dijk J, Magiera MM, et al. A family of protein-deglutamylating enzymes associated with neurodegeneration. Cell. 2010; 143: 564-78.
50. Ivie SE, Fennessey CM, Sheng J, et al. Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens epsilon-toxin. PLoS ONE. 2011; 6: e17787.
51. Guardiola-Serrano F, Haendeler J, Lukosz M, et al. Gene trapping identifies a putative tumor suppressor and a new inducer of cell migration. Biochem Biophys Res Commun. 2008; 376: 748-52.
52. Sambasivan R, Pavlath GK, Dhawan J. A gene-trap strategy identifies quiescence-induced genes in synchronized myoblasts. J Biosci. 2008; 33: 27-44.